THEODORE ROSEN to Middle Aged
This is a "connection" page, showing publications THEODORE ROSEN has written about Middle Aged.
Connection Strength
0.351
-
The potential impact of ACOG guideline changes on genital melanoma detection rates in females: a retrospective cross-sectional analysis and implications for clinical practice. Arch Dermatol Res. 2025 Feb 19; 317(1):438.
Score: 0.061
-
A case of filgrastim-induced neutrophilic dermatosis of the dorsal hands in a patient with Felty Syndrome. Dermatol Online J. 2023 Dec 15; 29(6).
Score: 0.056
-
Probable African Tick Bite Fever in the United States. Yale J Biol Med. 2020 03; 93(1):49-54.
Score: 0.044
-
Indurated erythema of the neck and upper back. Int J Dermatol. 2019 Nov; 58(11):1255-1257.
Score: 0.041
-
BRCA1-Associated Protein-1 Tumor Predisposition Syndrome in a Patient With Numerous Basal Cell Carcinomas. Dermatol Surg. 2019 02; 45(2):316-318.
Score: 0.040
-
Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol. 2013 Jan; 68(1 Suppl 1):S2-9.
Score: 0.026
-
The rate of melanoma transection with various biopsy techniques and the influence of tumor transection on patient survival. J Am Acad Dermatol. 2013 Mar; 68(3):452-8.
Score: 0.026
-
Etanercept therapy for silicone granuloma. J Drugs Dermatol. 2006 Oct; 5(9):894-6.
Score: 0.017
-
Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials. J Drugs Dermatol. 2018 Oct 01; 17(10):1051-1057.
Score: 0.010
-
A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment. J Drugs Dermatol. 2018 Oct 01; 17(10):1100-1105.
Score: 0.010
-
Recurrence of moderately dysplastic nevi with positive histologic margins. J Am Acad Dermatol. 2017 Mar; 76(3):527-530.
Score: 0.009
-
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles. J Am Acad Dermatol. 2010 Apr; 62(4):573-81.
Score: 0.005
-
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol. 2007 Oct; 6(10):1001-8.
Score: 0.005